Myricx Bio
Myricx Bio is an antibody-drug conjugate (ADC) payload platform founded in 2019.
2
Funding Rounds
$126.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Myricx Bio has raised a total of $126m in funding over 2 rounds.
Key Insights:
- Myricx Bio July 2024 Series A Funding Round: $120m
- Myricx Seed round, November 2020: $6m
Myricx Bio July 2024 Series A Funding Round
$120m
Myricx Seed round, November 2020
$6m
Industries
Myricx Bio is active in the following industries: